CIM Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

CIM Investment Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.54M	Sell	3,129 -15	-0.5%	-$8.14K	0.41%	40
2025 Q4	$1.82M	Hold	3,144	–	–	0.48%	34
2025 Q3	$1.52M	Sell	3,144 -32	-1%	-$14.9K	0.41%	38
2025 Q2	$1.29M	Sell	3,176 -13	-0.4%	-$5.43K	0.25%	87
2025 Q1	$1.59M	Sell	3,189 -2	-0.1%	-$1.08K	0.36%	30
2024 Q4	$1.66M	Buy	3,191 +1	+0%	+$550	0.49%	28
2024 Q3	$1.97M	Sell	3,190 -73	-2%	-$43.2K	0.58%	28
2024 Q2	$1.8M	Sell	3,263 -24	-0.7%	-$13.7K	0.56%	26
2024 Q1	$1.91M	Hold	3,287	–	–	0.57%	24
2023 Q4	$1.74M	Sell	3,287 -263	-7%	-$127K	0.56%	21
2023 Q3	$1.8M	Sell	3,550 -77	-2%	-$41K	0.66%	20
2023 Q2	$1.89M	Buy	3,627 +8	+0.2%	+$4.32K	0.64%	19
2023 Q1	$2.09M	Buy	3,619 +158	+5%	+$89.1K	0.77%	17
2022 Q4	$1.91M	Sell	3,461 -86	-2%	-$45.6K	0.75%	16
2022 Q3	$1.8M	Buy	3,547 +45	+1%	+$25.2K	0.8%	17
2022 Q2	$1.9M	Sell	3,502 -17	-0.5%	-$9.36K	0.79%	16
2022 Q1	$2.08M	Buy	3,519 +874	+33%	+$502K	0.7%	16
2021 Q4	$1.76M	Buy	2,645 +1,307	+98%	+$816K	0.53%	23
2021 Q3	$764K	Sell	1,338 -1,297	-49%	-$712K	0.24%	86
2021 Q2	$1.33M	Buy	2,635 +951	+56%	+$449K	0.41%	35
2021 Q1	$769K	Sell	1,684 -58	-3%	-$27.7K	0.24%	78
2020 Q4	$811K	Sell	1,742 -1,803	-51%	-$845K	0.26%	69
2020 Q3	$1.56M	Sell	3,545 -34	-0.9%	-$14K	0.59%	22
2020 Q2	$1.3M	Sell	3,579 -1,790	-33%	-$600K	0.52%	27
2020 Q1	$1.52M	Buy	5,369 +172	+3%	+$54.2K	0.75%	16
2019 Q4	$1.69M	Hold	5,197	–	–	0.67%	19
2019 Q3	$1.51M	Sell	5,197 -516	-9%	-$148K	0.57%	19
2019 Q2	$1.68M	Buy	5,713 +2,494	+77%	+$687K	0.61%	18
2019 Q1	$881K	Hold	3,219	–	–	0.34%	48
2018 Q4	$720K	Sell	3,219 -122	-4%	-$28.6K	0.31%	60
2018 Q3	$815K	Sell	3,341 -1	-0%	-$230	0.29%	71
2018 Q2	$692K	Sell	3,342 -88	-3%	-$18.7K	0.24%	99
2018 Q1	$708K	Sell	3,430 -79	-2%	-$16.6K	0.24%	110
2017 Q4	$666K	Sell	3,509 -50	-1%	-$9.58K	0.23%	115
2017 Q3	$673K	Sell	3,559 -205	-5%	-$37.1K	0.24%	100
2017 Q2	$657K	Sell	3,764 -256	-6%	-$43K	0.23%	104
2017 Q1	$617K	Sell	4,020 -348	-8%	-$53.2K	0.21%	117
2016 Q4	$616K	Buy	4,368 +45	+1%	+$6.63K	0.22%	121
2016 Q3	$688K	Sell	4,323 -300	-6%	-$46.2K	0.26%	94
2016 Q2	$683K	Sell	4,623 -190	-4%	-$28K	0.28%	99
2016 Q1	$681K	Sell	4,813 -340	-7%	-$45.6K	0.3%	102
2015 Q4	$731K	Hold	5,153	–	–	0.33%	106
2015 Q3	$630K	Hold	5,153	–	–	0.3%	119
2015 Q2	$669K	Sell	5,153 -40	-0.8%	-$5.21K	0.29%	121
2015 Q1	$698K	Hold	5,193	–	–	0.3%	124
2014 Q4	$651K	Hold	5,193	–	–	0.3%	128
2014 Q3	$632K	Sell	5,193 -22	-0.4%	-$2.67K	0.32%	129
2014 Q2	$615K	Sell	5,215 -171	-3%	-$20.1K	0.31%	130
2014 Q1	$648K	Buy	+5,386	New	+$640K	0.3%	125

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIM Investment Management's TMO Position: Q1 2026 in Review

CIM Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 0.48% in Q1 2026, selling an estimated $8.14K and leaving 3,129 shares worth $1.54M. The position accounts for 0.41% of the portfolio, ranked #40.

CIM Investment Management first reported a position in TMO in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.09M in Q1 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

CIM Investment Management held 3,129 shares of Thermo Fisher Scientific worth $1.54M as of Q1 2026.
CIM Investment Management sold 15 Thermo Fisher Scientific shares in Q1 2026, an estimated $8.14K.
Thermo Fisher Scientific made up 0.41% of CIM Investment Management's portfolio in Q1 2026, its #40 holding.
CIM Investment Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 49 quarters since.
CIM Investment Management's Thermo Fisher Scientific position peaked at $2.09M in Q1 2023.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.